NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock - Currency: USD
77.24
-0.81 (-1.04%)
The current stock price of HSIC is 77.24 USD. In the past month the price increased by 3.33%. In the past year, price decreased by -3.28%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.5 | 74.91B | ||
COR | CENCORA INC | 16.99 | 46.77B | ||
CAH | CARDINAL HEALTH INC | 16.44 | 30.69B | ||
PDCO | PATTERSON COS INC | 14.66 | 2.74B | ||
AHCO | ADAPTHEALTH CORP | N/A | 1.14B | ||
AHG | AKSO HEALTH GROUP | N/A | 518.47M | ||
OMI | OWENS & MINOR INC | 3.75 | 479.62M | ||
COSM | COSMOS HEALTH INC | N/A | 14.34M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 8.12M | ||
ATPC | AGAPE ATP CORP | N/A | 3.73M |
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. The firm operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. The company offers dental practice management solutions for dental and medical practitioners. The company also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).
HENRY SCHEIN INC
135 Duryea Rd
Melville NEW YORK 11747 US
CEO: Stanley M. Bergman
Employees: 26000
Company Website: https://www.henryschein.com/
Investor Relations: https://investor.henryschein.com
Phone: 16318435500
The current stock price of HSIC is 77.24 USD. The price decreased by -1.04% in the last trading session.
The exchange symbol of HENRY SCHEIN INC is HSIC and it is listed on the Nasdaq exchange.
HSIC stock is listed on the Nasdaq exchange.
21 analysts have analysed HSIC and the average price target is 77.52 USD. This implies a price increase of 0.36% is expected in the next year compared to the current price of 77.24. Check the HENRY SCHEIN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HENRY SCHEIN INC (HSIC) has a market capitalization of 9.59B USD. This makes HSIC a Mid Cap stock.
HENRY SCHEIN INC (HSIC) currently has 26000 employees.
HENRY SCHEIN INC (HSIC) has a support level at 77.03 and a resistance level at 79.85. Check the full technical report for a detailed analysis of HSIC support and resistance levels.
The Revenue of HENRY SCHEIN INC (HSIC) is expected to grow by 3.51% in the next year. Check the estimates tab for more information on the HSIC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HSIC does not pay a dividend.
HENRY SCHEIN INC (HSIC) will report earnings on 2025-02-25, after the market close.
The PE ratio for HENRY SCHEIN INC (HSIC) is 18.35. This is based on the reported non-GAAP earnings per share of 4.21 and the current share price of 77.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for HSIC.
The outstanding short interest for HENRY SCHEIN INC (HSIC) is 4.7% of its float. Check the ownership tab for more information on the HSIC short interest.
ChartMill assigns a technical rating of 8 / 10 to HSIC. When comparing the yearly performance of all stocks, HSIC turns out to be only a medium performer in the overall market: it outperformed 41.41% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to HSIC. HSIC has only an average score on both its financial health and profitability.
Over the last trailing twelve months HSIC reported a non-GAAP Earnings per Share(EPS) of 4.21. The EPS decreased by -16.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.51% | ||
ROA | 2.96% | ||
ROE | 8.96% | ||
Debt/Equity | 0.73 |
ChartMill assigns a Buy % Consensus number of 75% to HSIC. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 7.88% and a revenue growth 3.51% for HSIC